Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TransMedics Group, Inc.TMDX · Entity 4261 | Chief Digital Officer | August 04, 2021 | August 06, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TransMedics Group, Inc.
Report date August 04, 2021 · Filed August 06, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.87 · Expires 2031-08-04 | Direct | 140,000 |
Reported balance
After 2021-08-04 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-08-04 · Grant · Acquired 140,000 · Balance 140,000 F1: The option vests as to 25% of the shares on the first anniversary of the Vesting Commencement Date, July 29, 2021, and as to the remaining shares in equal monthly installments over three years thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests as to 25% of the shares on the first anniversary of the Vesting Commencement Date, July 29, 2021, and as to the remaining shares in equal monthly installments over three years thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 04, 2021 Filed Aug 6, 2021 21:05 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantStock Option (Right to Buy) · Derivative | 140,000 | $0.00 Strike: $27.87 | $0.00 |
DisclosureSEC source: 0000899243-21-031931 · doc4.xml · derivative · entry 1 Godhani Rakesh P. · CIK 0001876878 · Chief Digital Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2031-08-04 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the Vesting Commencement Date, July 29, 2021, and as to the remaining shares in equal monthly installments over three years thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.